Home>Enzalutamide and olaparib synergistically suppress castration-resistant prostate cancer progression by promoting apoptosis through inhibiting nonhomologous end joining pathway
Enzalutamide and olaparib synergistically suppress castration-resistant prostate cancer progression by promoting apoptosis through inhibiting nonhomologous end joining pathway
- Impact factors: 3.054
- Publication: ASIAN JOURNAL OF ANDROLOGY
- Author:Dong Hui-Yu, Zang Pan, Bao Mei-Ling, Zhou Tian-Ren, Ni Chen-Bo, Ding Lei, Zhao Xu-Song, Li Jie, Liang Chao
- DOI citation-doi:10.4103/aja202316
- Date:2023-05-26